41 In a meta-analysis of nine RCTs involving 8,920 patients with HF and coexisting T2D, GLP-1 RAs did not improve LVEF, LV end-diastolic volume or LV end-systolic volume
The IRS classifies GLP-1 receptor agonists as qualifying medical expenses when prescribed by a licensed healthcare provider for weight management
GLP-1 Cost Drivers are Unique for Every CompanySo are the Approaches to Cost Management Given the diversity of member profiles across companies, the factors driving GLP-1 costs look very different across organizations
Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an exclusive TODAY interview on Aug
In those who stopped using GLP-1 compared with those who stayed on the medication, heart risks began to rise several months after stopping: by 4% at six months, by 14% at one year, and by 22% at the second year almost erasing the benefits gained